Sleep Medicine Reviews最新文献

英文中文

Sleep and the Mediterranean diet: A systematic review and meta-analysis

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-07 DOI: 10.1016/j.smrv.2025.102071

Arman Arab , Ioannis G. Lempesis , Marta Garaulet , Frank A.J.L. Scheer

We conducted the current systematic review and meta-analysis to critically review and synthesize available evidence regarding the association between sleep duration, sleep quality, and chronotype with the Mediterranean diet (MedDiet) among the general population using observational studies. Online databases, including PubMed, Scopus, and ISI Web of Science, were searched from the earliest available date until December 2024. We enrolled 62 studies with a total sample size of 328,493. The mean age and BMI of the participants in the enrolled studies ranged from 6.1 to 74.7 years and 18.1–32.1 kg/m². Individuals with sufficient sleep duration (OR: 1.39; 95 % CI, 1.04, 1.85; P = 0.030; I² = 97.89 %, P_Q-test < 0.001), good-quality sleep (OR: 1.38; 95 % CI, 1.10, 1.73; P < 0.001; I² = 93.83 %, P_Q-test < 0.001), and earlier chronotype (OR: 1.93; 95 % CI, 1.26, 2.95; P = 0.002; I² = 89.92 %, P_Q-test < 0.001) had significantly increased odds of high MedDiet scores, compared to those with insufficient sleep duration, poor-quality sleep, and later chronotype, respectively. Our study revealed that sleep duration, sleep quality, and chronotype are lifestyle-related factors linked to MedDiet. However, more longitudinal studies and clinical trials are needed to investigate causality, mediating factors, and underlying mechanisms.

{"title":"Sleep and the Mediterranean diet: A systematic review and meta-analysis","authors":"Arman Arab , Ioannis G. Lempesis , Marta Garaulet , Frank A.J.L. Scheer","doi":"10.1016/j.smrv.2025.102071","DOIUrl":"10.1016/j.smrv.2025.102071","url":null,"abstract":"<div><div>We conducted the current systematic review and meta-analysis to critically review and synthesize available evidence regarding the association between sleep duration, sleep quality, and chronotype with the Mediterranean diet (MedDiet) among the general population using observational studies. Online databases, including PubMed, Scopus, and ISI Web of Science, were searched from the earliest available date until December 2024. We enrolled 62 studies with a total sample size of 328,493. The mean age and BMI of the participants in the enrolled studies ranged from 6.1 to 74.7 years and 18.1–32.1 kg/m<sup>2</sup>. Individuals with sufficient sleep duration (OR: 1.39; 95 % CI, 1.04, 1.85; <em>P</em> = 0.030; <em>I</em><sup><em>2</em></sup> = 97.89 %, <em>P</em><sub><em>Q-test</em></sub> < 0.001), good-quality sleep (OR: 1.38; 95 % CI, 1.10, 1.73; <em>P</em> < 0.001; <em>I</em><sup><em>2</em></sup> = 93.83 %, <em>P</em><sub><em>Q-test</em></sub> < 0.001), and earlier chronotype (OR: 1.93; 95 % CI, 1.26, 2.95; <em>P</em> = 0.002; <em>I</em><sup><em>2</em></sup> = 89.92 %, <em>P</em><sub><em>Q-test</em></sub> < 0.001) had significantly increased odds of high MedDiet scores, compared to those with insufficient sleep duration, poor-quality sleep, and later chronotype, respectively. Our study revealed that sleep duration, sleep quality, and chronotype are lifestyle-related factors linked to MedDiet. However, more longitudinal studies and clinical trials are needed to investigate causality, mediating factors, and underlying mechanisms.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102071"},"PeriodicalIF":11.2,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143611049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Corrigendum to “Treatment effect heterogeneity of cognitive behavioral therapy for insomnia – A meta-analysis” [Sleep Medicine Reviews 77 (2024) 101966]

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-04 DOI: 10.1016/j.smrv.2025.102064

Lisa Steinmetz , Laura Simon , Harald Baumeister , Kai Spiegelhalder , Yannik Terhorst

引用次数: 0

Comment on Pereira et al. Prevalence of depression in pediatric patients with diagnosed or at high risk for obstructive sleep apnea: A systematic review with meta-analysis

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-01 DOI: 10.1016/j.smrv.2025.102066

Jian Huang

引用次数: 0

Response to commentary on “Prevalence of depression in pediatric patients with diagnosed or at high risk for obstructive sleep apnea: A systematic review with meta-analysis”

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-01 DOI: 10.1016/j.smrv.2025.102067

引用次数: 0

Do sleepless nights turn into painful days? Opportunities and challenges in detecting and synthesising the day-to-day sleep-pain relationship 不眠之夜会变成痛苦的白天吗？发现和综合日常睡眠-疼痛关系的机遇和挑战。

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-01 DOI: 10.1016/j.smrv.2024.102045

Nicole K.Y. Tang

引用次数: 0

A commentary on the article: "Treatment effect heterogeneity of cognitive behavioral therapy for insomnia-A meta-analysis"

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-01-29 DOI: 10.1016/j.smrv.2025.102063

Jialin Wang , Zhoupeng Lu , Peng Zhao , Benxiang He

引用次数: 0

The dentofacial and upper airway morphology of adults with obstructive sleep apnea: A systematic review and meta-analysis

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-01-23 DOI: 10.1016/j.smrv.2025.102065

Zeyu Wei , Tingting Zhao , Yaqi Li , Peter Ngan , Zhenhui Wang , Fang Hua , Hong He

The purpose of this systematic review is to summarize evidence regarding the dentofacial and upper airway features of obstructive sleep apnea (OSA) with adults. This systematic review included 32 cross-sectional studies that compared characteristics ascertained from lateral cephalograms or cone beam computed tomography (CBCT) in adults with and without OSA. Comprehensive searches were conducted in PubMed, Embase, and Web of Science from inception to December 2024. Meta-analyses revealed that the inter-first premolar distance (MD = −2.01, P < 0.00001), sella nasion plane length (SN, MD = −2.08, P < 0.00001), posterior airway space (PAS, MD = −1.95, P = 0.03) were notably smaller in the OSA group compared to controls. Conversely, anterior total facial height (ATFH, MD = 2.66, P < 0.0001), the soft palate length (UL, MD = 5.41, P < 0.00001) and the angle constituted by subspinale, nasion and supramentale (ANB, MD = 0.64, P = 0.01) were significantly larger in the OSA group. In comparison to healthy individuals, it is evident that OSA patients may present with a constricted maxillary arch, underdeveloped and clockwise-rotated mandible, augmented vertical facial growth, an inferiorly positioned hyoid bone, and a diminished pharyngeal airway space.

{"title":"The dentofacial and upper airway morphology of adults with obstructive sleep apnea: A systematic review and meta-analysis","authors":"Zeyu Wei , Tingting Zhao , Yaqi Li , Peter Ngan , Zhenhui Wang , Fang Hua , Hong He","doi":"10.1016/j.smrv.2025.102065","DOIUrl":"10.1016/j.smrv.2025.102065","url":null,"abstract":"<div><div>The purpose of this systematic review is to summarize evidence regarding the dentofacial and upper airway features of obstructive sleep apnea (OSA) with adults. This systematic review included 32 cross-sectional studies that compared characteristics ascertained from lateral cephalograms or cone beam computed tomography (CBCT) in adults with and without OSA. Comprehensive searches were conducted in PubMed, Embase, and Web of Science from inception to December 2024. Meta-analyses revealed that the inter-first premolar distance (MD = −2.01, P < 0.00001), sella nasion plane length (SN, MD = −2.08, P < 0.00001), posterior airway space (PAS, MD = −1.95, P = 0.03) were notably smaller in the OSA group compared to controls. Conversely, anterior total facial height (ATFH, MD = 2.66, P < 0.0001), the soft palate length (UL, MD = 5.41, P < 0.00001) and the angle constituted by subspinale, nasion and supramentale (ANB, MD = 0.64, P = 0.01) were significantly larger in the OSA group. In comparison to healthy individuals, it is evident that OSA patients may present with a constricted maxillary arch, underdeveloped and clockwise-rotated mandible, augmented vertical facial growth, an inferiorly positioned hyoid bone, and a diminished pharyngeal airway space.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102065"},"PeriodicalIF":11.2,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sleep alterations in major depressive disorder and insomnia disorder: A network meta-analysis of polysomnographic studies

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-01-15 DOI: 10.1016/j.smrv.2025.102048

Caterina Leitner , Francesca Dalle Piagge , Tijana Tomic , Federica Nozza , Elisabetta Fasiello , Vincenza Castronovo , Luigi De Gennaro , Chiara Baglioni , Luigi Ferini-Strambi , Andrea Galbiati

Major depressive disorder (MDD) and Insomnia disorder (ID) are characterized by sleep alterations. To define their polysomnographic profiles, we conducted a Network Meta-Analysis comparing MDD and ID patients versus healthy controls (HCs). The literature search, conducted from 2008 up to January 2023 and following PRISMA guidelines, covered PubMed, Web of Science, Scopus, and Embase databases. We addressed publication bias using funnel plot asymmetry inspection and Egger’s test, evaluated statistical heterogeneity with I², and local and global inconsistencies with the separate indirect from direct evidence method and Q between designs, respectively. Pairwise meta-analyses employed a fixed-effects model, while network analysis utilized a random-effect approach. We evaluated 86 ID and 17 MDD studies, comparing sleep parameters for 636 MDDs versus 491 HCs, and 3661 IDs versus 2792 HCs. The network meta-analysis reported that patients with MDD have greater rapid eye movement (REM) sleep duration and REMs density, and lower REM sleep latency compared to IDs. ID patients instead exhibited lower total sleep time and time in bed, and greater wake after sleep onset and non-REM sleep stage 3 than MDD patients. This work emphasized sleep depth and continuity alterations in both MDD and ID, with major involvement of REM sleep in MDD.

{"title":"Sleep alterations in major depressive disorder and insomnia disorder: A network meta-analysis of polysomnographic studies","authors":"Caterina Leitner , Francesca Dalle Piagge , Tijana Tomic , Federica Nozza , Elisabetta Fasiello , Vincenza Castronovo , Luigi De Gennaro , Chiara Baglioni , Luigi Ferini-Strambi , Andrea Galbiati","doi":"10.1016/j.smrv.2025.102048","DOIUrl":"10.1016/j.smrv.2025.102048","url":null,"abstract":"<div><div>Major depressive disorder (MDD) and Insomnia disorder (ID) are characterized by sleep alterations. To define their polysomnographic profiles, we conducted a Network Meta-Analysis comparing MDD and ID patients <em>versus</em> healthy controls (HCs). The literature search, conducted from 2008 up to January 2023 and following PRISMA guidelines, covered PubMed, Web of Science, Scopus, and Embase databases. We addressed publication bias using funnel plot asymmetry inspection and Egger’s test, evaluated statistical heterogeneity with I<sup>2</sup>, and local and global inconsistencies with the separate indirect from direct evidence method and Q between designs, respectively. Pairwise meta-analyses employed a fixed-effects model, while network analysis utilized a random-effect approach. We evaluated 86 ID and 17 MDD studies, comparing sleep parameters for 636 MDDs <em>versus</em> 491 HCs, and 3661 IDs <em>versus</em> 2792 HCs. The network meta-analysis reported that patients with MDD have greater rapid eye movement (REM) sleep duration and REMs density, and lower REM sleep latency compared to IDs. ID patients instead exhibited lower total sleep time and time in bed, and greater wake after sleep onset and non-REM sleep stage 3 than MDD patients. This work emphasized sleep depth and continuity alterations in both MDD and ID, with major involvement of REM sleep in MDD.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102048"},"PeriodicalIF":11.2,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143562762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder: A systematic review and meta-analysis 认知行为疗法治疗酒精中毒性失眠症：系统回顾和荟萃分析。

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-01-11 DOI: 10.1016/j.smrv.2025.102049

Cagdas Türkmen , Carlotta L. Schneider , Wolfgang Viechtbauer , Ingeborg Bolstad , Subhajit Chakravorty , Mary Beth Miller , Håvard Kallestad , Guro W. Angenete , Anna F. Johann , Bernd Feige , Kai Spiegelhalder , Dieter Riemann , Øystein Vedaa , Ståle Pallesen , Elisabeth Hertenstein

Insomnia is prevalent among patients with alcohol use disorder (AUD), potentially undermining treatment and increasing the risk of relapse. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for insomnia, but its efficacy is not well-characterized in patients across the spectrum of AUD. The aim of this meta-analysis was to quantify the effectiveness of CBT-I in improving insomnia severity and alcohol-related outcomes in adults with heavy alcohol use and/or varying levels of AUD severity and comorbid insomnia. MEDLINE, Cochrane Library, PsycINFO and ClinicalTrials.gov were systematically searched (up to February 2024) to retrieve randomized controlled trials (RCTs). Multilevel meta-analyses were conducted to estimate mean differences over time in insomnia severity, measured using the Insomnia Severity Index (ISI), as well as in alcohol craving and alcohol-related psychosocial problems between CBT-I and control groups. For the number of heavy-drinking/abstinent days, incidence rate ratios were estimated. Risk of bias was assessed using the Risk of Bias 2 (RoB 2) tool. Eight RCTs encompassing 426 adults (68.78 % men) were included. Compared with control conditions, CBT-I resulted in a large reduction of insomnia severity post-treatment [estimated ISI reduction = −5.51, 95% CI (−7.13 to −3.90)], which was maintained at 1-to-3-month [7 studies; estimate = −4.39, 95% CI (−6.08 to −2.70)], and 6-month follow-up [4 studies; estimate = −4.55, 95% CI (−6.77 to −2.33)]. Alcohol-related outcomes were reported less consistently, and no significant differences were found. The included trials were judged to have a low or moderate overall risk of bias for the assessment of all outcomes. CBT-I effectively reduces insomnia severity across the spectrum of AUD, supporting wide implementation in AUD prevention and treatment settings.

PROSPERO registration number

CRD42023464612.

{"title":"Cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder: A systematic review and meta-analysis","authors":"Cagdas Türkmen , Carlotta L. Schneider , Wolfgang Viechtbauer , Ingeborg Bolstad , Subhajit Chakravorty , Mary Beth Miller , Håvard Kallestad , Guro W. Angenete , Anna F. Johann , Bernd Feige , Kai Spiegelhalder , Dieter Riemann , Øystein Vedaa , Ståle Pallesen , Elisabeth Hertenstein","doi":"10.1016/j.smrv.2025.102049","DOIUrl":"10.1016/j.smrv.2025.102049","url":null,"abstract":"<div><div>Insomnia is prevalent among patients with alcohol use disorder (AUD), potentially undermining treatment and increasing the risk of relapse. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for insomnia, but its efficacy is not well-characterized in patients across the spectrum of AUD. The aim of this meta-analysis was to quantify the effectiveness of CBT-I in improving insomnia severity and alcohol-related outcomes in adults with heavy alcohol use and/or varying levels of AUD severity and comorbid insomnia. MEDLINE, Cochrane Library, PsycINFO and ClinicalTrials.gov were systematically searched (up to February 2024) to retrieve randomized controlled trials (RCTs). Multilevel meta-analyses were conducted to estimate mean differences over time in insomnia severity, measured using the Insomnia Severity Index (ISI), as well as in alcohol craving and alcohol-related psychosocial problems between CBT-I and control groups. For the number of heavy-drinking/abstinent days, incidence rate ratios were estimated. Risk of bias was assessed using the Risk of Bias 2 (RoB 2) tool. Eight RCTs encompassing 426 adults (68.78 % men) were included. Compared with control conditions, CBT-I resulted in a large reduction of insomnia severity post-treatment [estimated ISI reduction = <strong>−</strong>5.51, 95% CI (<strong>−</strong>7.13 to −3.90)], which was maintained at 1-to-3-month [7 studies; estimate = −4.39, 95% CI (<strong>−</strong>6.08 to −2.70)], and 6-month follow-up [4 studies; estimate = −4.55, 95% CI (<strong>−</strong>6.77 to −2.33)]. Alcohol-related outcomes were reported less consistently, and no significant differences were found. The included trials were judged to have a low or moderate overall risk of bias for the assessment of all outcomes. CBT-I effectively reduces insomnia severity across the spectrum of AUD, supporting wide implementation in AUD prevention and treatment settings.</div></div><div><h3>PROSPERO registration number</h3><div>CRD42023464612.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102049"},"PeriodicalIF":11.2,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

AI-enhanced imagery rehearsal therapy: A novel approach to treating nightmare disorder 人工智能增强的意象排练疗法：一种治疗噩梦障碍的新方法。

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2024-12-17 DOI: 10.1016/j.smrv.2024.102046

Michal Kahn

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Sleep Medicine Reviews

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀